Cargando…
Anti-SARS-CoV-2 Spike Protein RBD Antibody Levels After Receiving a Second Dose of ChAdOx1 nCov-19 (AZD1222) Vaccine in Healthcare Workers: Lack of Association With Age, Sex, Obesity, and Adverse Reactions
Response to vaccines generally varies according to individual factors of the vaccinated subjects such as demographics and immune status. While there are various reports of factors associated with immunogenicity of mRNA COVID-19 vaccines, little is known about those of adenovirus vector vaccines. We...
Autores principales: | Lee, Sang Won, Moon, Ji-Yong, Lee, Sun-Kyung, Lee, Hyun, Moon, SeolHwa, Chung, Sung Jun, Yeo, Yoomi, Park, Tai Sun, Park, Dong Won, Kim, Tae-Hyung, Sohn, Jang Won, Yoon, Ho Joo, Kim, Sang-Heon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8654782/ https://www.ncbi.nlm.nih.gov/pubmed/34899739 http://dx.doi.org/10.3389/fimmu.2021.779212 |
Ejemplares similares
-
Risk Factors for Grade 3 to Grade 4 Adverse Reactions to the ChAdOx1 nCoV-19 Vaccine (AZD1222) Against SARS-CoV-2
por: Lee, Sang Won, et al.
Publicado: (2021) -
Anti-SARS-CoV-2 Neutralizing Antibody Responses after Two Doses of ChAdOx1 nCoV-19 vaccine (AZD1222) in Healthcare Workers
por: Lim, Sera, et al.
Publicado: (2022) -
AZD1222 (ChAdOx1 nCov-19): A Single-Dose biodistribution study in mice
por: Stebbings, Richard, et al.
Publicado: (2022) -
Thrombosis with thrombocytopenia after AZD1222 (ChAdOx1 nCov-19) vaccination: Case characteristics and associations
por: Laffan, Michael A, et al.
Publicado: (2022) -
Immunogenicity after Second ChAdOx1 nCoV-19 (AZD1222) Vaccination According to the Individual Reactogenicity, Health Status and Lifestyle
por: Choi, Hyunji, et al.
Publicado: (2021)